US Bancorp’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-19
Closed -$950 4137
2023
Q3
$950 Buy
+19
New +$950 ﹤0.01% 3755
2022
Q1
Sell
-4
Closed -$1K 4191
2021
Q4
$1K Sell
4
-7
-64% -$1.75K ﹤0.01% 4015
2021
Q3
$6K Buy
11
+4
+57% +$2.18K ﹤0.01% 3583
2021
Q2
$3K Buy
+7
New +$3K ﹤0.01% 3748